C4 Therapeutics, Inc. (CCCC)
NASDAQ·Healthcare·Biotechnology
$2.58
-6.20%
Mkt Cap $234.40M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (11 analysts)
$8.50
Range $7.00 – $10.00
Implied Upside
+229.5%
Consensus $8.50 vs current $2.58
NASDAQ·Healthcare·Biotechnology
$2.58
-6.20%
Mkt Cap $234.40M
Buy
3
Hold
0
Sell
0
Price Target (11 analysts)
$8.50
Range $7.00 – $10.00
+229.5%
Consensus $8.50 vs current $2.58